Showing results (361-370 of 404) with videos related to
Sort By:
Pageof 41
Bone Marrow Transplantation|August 16, 2002
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in EuropeA Urbano-Ispizua, N Schmitz, T de Witte, et al.Bone Marrow Transplantation|April 30, 2014
Challenges and opportunities for HSCT outcome registries: perspective from international HSCT registries expertsM Aljurf, J D Rizzo, M Mohty, et al.British Journal of Haematology|September 21, 2000
Haematopoietic stem cell transplantation for patients with myelo-dysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)T de Witte, J Hermans, J Vossen, et al.Bone Marrow Transplantation|January 27, 2004
Outbreaks of infectious diseases in stem cell transplant units: a silent cause of death for patients and transplant programmesS McCann, J L Byrne, M Rovira, et al.Bone Marrow Transplantation|March 7, 1998
Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome. Chronic Leukemia Working Party of the European Group for Blood and Marrow TransplantationV Runde, T de Witte, R Arnold, et al.Infection|July 18, 2012
Human metapneumovirus infection after allogeneic hematopoietic stem cell transplantationA Egli, C Bucher, A Dumoulin, et al.Blood|May 29, 2000
Risk assessment in patients with Ph+ chronic myelogenous leukemia at first relapse after allogeneic stem cell transplant: an EBMT retrospective analysis. The Chronic Leukemia Working Party of the European Group for Blood and Marrow TransplantationC Guglielmi, W Arcese, J Hermans, et al.Bone Marrow Transplantation|July 9, 2009
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009P Ljungman, M Bregni, M Brune, et al.Bone Marrow Transplantation|June 19, 1998
Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow TransplantationN Schmitz, A Bacigalupo, D Hasenclever, et al.Blood|October 6, 2001
Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDST de Witte, S Suciu, G Verhoef, et al.Pageof 41